I am a pathophysiologist focusing on regenerative medicine, stem cell therapy, and new methods for liver fibrosis treatment. I received my PhD in 2025 from the Department of Pathological Physiology at Ural State Medical University (Yekaterinburg, Russia), where I successfully developed a novel non-surgical approach to treating liver fibrosis in mice using a combination of placenta-derived mesenchymal stromal cells and fucoxanthin. I also have research experience with enteric viruses.
Slautin, V.;Ivanov, V.; Bugakov, A.; Chernysheva, A.; Gavrilov, I.; Maklakova, I.; Bazarnyi, V.; Grebnev, D.; Kovtun, O. Preconditioning with Rapamycin Improves Therapeutic Potential of Placenta-Derived Mesenchymal Stem Cells in Mouse Model of Hematopoietic Acute Radiation Syndrome. Int. J. Mol. Sci. 2025, 26, 4804. https://doi.org/10.3390/ijms26104804
Slautin Vasilii, Konyshev Konstantin, Gavrilov Ilya, Beresneva Olga, Maklakova Irina and Grebnev Dmitry. Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver Fibrosis, Current Stem Cell Research & Therapy 2024; 19. https://dx.doi.org/10.2174/011574888X279940231206100902
Slautin, V.N., Grebnev, D.Y., Maklakova, I.Y. et al. Fucoxanthin exert dose-dependent antifibrotic and anti-inflammatory effects on CCl4-induced liver fibrosis. J Nat Med 77, 953–963 (2023). https://doi.org/10.1007/s11418-023-01723-9.
Itani TM, Chalapa VI, Slautin VN, Bykov RO, Imangaliev BS, Starikova PK, Sergeev AG, Semenov AV. Non-Polio Enterovirus Surveillance in the Ural Federal District and Western Siberia, 2022: Is There a Need for a Vaccine? Vaccines (Basel). 2023 Oct 12;11(10):1588. doi: 10.3390/vaccines11101588.
Itani, T.M., Chalapa, V.I., Slautin, V.N. et al. Circulation of non-polio enteroviruses in the Ural Federal District and Western Siberia in 2023: the return of an old foe? Arch Virol 170, 110 (2025). https://doi.org/10.1007/s00705-025-06284-8
